system in lung cancer and the previous failures of immunotherapy for patients with lung cancer. We then provide an overview of the existing evidence for the use of icis in patients with advanced nsclc that is either treatment-naïve or pretreated, for consolidative treatment after chemoradiotherapy in stage iii nsclc, and for palliative therapy in patients with sclc. Finally, we discuss duration of treatment, special populations, and the future of immuno-oncology for
Effect of nasal septum correction under nasal endoscope on serum ECP,TIgE and IL⁃6levels in patients with OSAHS and chronic rhinosinusitis 期刊:J Mol Diagn Ther, June 2023, Vol. 15 No. 6 作者:WANG Hongxin,SHI Baoyu★ , AN Na DOI:10.19930/j.cnki.jmdt.2023.06.025